• Species Reactivity

  Human, Mouse, Rat

• Specificity

  Detects human, mouse, and rat NIPP1 in Western blots and detects recombinant human NIPP1 in direct ELISAs.

• Source

  Polyclonal Sheep IgG

• Purification

  Antigen Affinity-purified

• Immunogen

  E. coli-derived recombinant human NIPP1    
  Ala2-Ile351    
  Accession # Q12972

• Formulation

  Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.

• Label

  Unconjugated

Applications

• Recommended    
  Concentration

  Sample

• Western Blot

  0.5 μg/mL

  See below

• 
  

Please Note: Optimal dilutions should be determined by each laboratory for each application.  are available in the Technical Information section on our website.

Data Examples

Preparation and Storage

• Reconstitution

  Sterile PBS to a final concentration of 0.2 mg/mL.

• Shipping

  The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C

• Stability & Storage

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles.    

• 12 months from date of receipt, -20 to -70 °C as supplied.

• 1 month, 2 to 8 °C under sterile conditions after reconstitution.

• 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: NIPP1

NIPP1 (Nuclear Inhibitory polypeptide of Protein Phosphatase 1; also ARD-1 and PPP1R8) is a 41 kDa intracellular protein that belongs to no known molecular family. Although it is ubiquitously expressed, it does undergo alternative splicing, and distinct isoforms are associated with distinct tissues. In the nucleus, NIPP1 complexes with PP1c, targeting it to either RNA or chromatin. This is accompanied by the additional recruitment of other molecules such as Sap155 and PRC2. When nonphosphorylated, NIPP1 blocks PP1c activity; when phosphorylated, NIPP1 allows for PP1c activity, and this impacts the processes of both pre-mRNA splicing and gene silencing. Human NIPP1 is 351 amino acids (aa) in length. It contains an N-terminal FHA domain (aa 49-101), an NLS (aa 185-209), a PP1 binding site (aa 191-210), another NLS (aa 210-240) and an RNA binding site (aa 330-351). There are two potential splice variants. Both possess alternative start sites, one at Met143 (called NIPP1 beta ), and another at Met225 (called ARD-1 or NIPP1 gamma ). Full-length human NIPP1 shares 98% aa sequence identity with mouse NIPP1.

• Long Name:

  Nuclear Inhibitor of Protein Phosphatase 1

• Entrez Gene IDs:

  5511 (Human); 100336 (Mouse); 313030 (Rat)

• Alternate Names:

  activator of RNA decay; ARD1; ard-1; ARD1nuclear inhibitor of protein phosphatase 1; NIPP1; NIPP1nuclear inhibitor of protein phosphatase-1; NIPP-1nuclear subunit of PP-1; PPP1R8; PRO2047; Protein phosphatase 1 regulatory inhibitor subunit 8; protein phosphatase 1 regulatory subunit 8; protein phosphatase 1, regulatory (inhibitor) subunit 8; RNase E